June 23


Lunch Session - Global Sessions in Urology

Welcome VIEW
Review of Lancet Commission on Global Surgery Summary
Rajiv K. Singal
Jacques Corcos
Building GU capacity in Malawi Africa
Rajiv K. Singal
Questions and Answers VIEW

State-of-the-Art Lecture 1

Self Awareness and effective leadership
Jamie Campbell

State-of-the-Art Lecture 2

Musings of a former deputy health minister
Kevin McNamara

State-of-the-Art Lecture 3

eCommunications: Using email, texting and social media wisely
Lorraine LeGrand-Westfall

CUOG Lecture

The revolution of immunotherapy in genito-urinary cancers: The tip of the iceberg
Yves Fradet

Early or late: The CRPC management debate

Bobby Shayegan, Kim Chi, Naveen Basappa and Ricardo A. Rendon VIEW

June 24


State-of-the-Art Lecture 4

Prostate Cancer: A disease of our time
Freddie Hamdy

Educational Forum 1: Evolving approaches in diagnosing prostate cancer: Beyond PSA

Franck Bladou, Freddie Hamdy, Frédéric Pouliot VIEW

Podium Session 1: Prostate Cancer

PROSPER: A phase 3, randomized, double-blind, placebo-controlled study of enzalutamide in men with non-metastatic castration-resistant prostate cancer
Fred Saad
Serum sex steroids as prognostic biomarkers in patients receiving androgen-deprivation therapy for recurrent prostate cancer post-radiotherapy: A post-hoc analysis of the PR.7 trial
Paul Toren
Metastatic castrate-resistant prostate cancer treatment algorithm: A shifting paradigm
Bobby Shayegan
Prostate cancer incidence and mortality in Saskatchewan men on 5α-reductase inhibitors and α-blockers for benign prostatic hyperplasia (1995-2014)
J. Curtis Nickel
Salvage cryoablation for recurrent prostate cancer following radiation therapy: Long-term outcomes from a combined analysis of two centres
Joseph Chin
A prospective multicentre study comparing multi-parametric MRI (mp-MRI), F-18-choline (FCH) and Ga-68-PSMA PET/CT in patients being considered for salvage radiation therapy after radical prostatectomy
Frédéric Pouliot

State-of-the-Art Lecture 5

Disruptive Innovation in Urology:  Are you ready for it?
Brian Goldman

Allied Urology Association Address

AUA Address
Robert C. Flanigan
EAU Address
Frans M.J. Debruyne

CUASF Lecture

Translating bladder cancer genomics into clinical practice
Peter C. Black

State-of-the-Art Lecture 6

Testis Cancer: Personal approach to managing controversies
Joel Sheinfeld

Educational Forum 2: Controversial surgical oncology debates (One video for the entire session)

Metastatic Kidney Cancer: Cytoreductive nephrectomy in the Era of TKI systemic therapy
Rodney H. Breau
Testicular Cancer: Management of the low volume post-chemotherapy NSGCT retroperitoneal mass
Joel Sheinfeld
Testicular Cancer: Management of the low volume post-chemotherapy NSGCT retroperitoneal mass
Robert Hamilton
Metastatic Kidney Cancer: Cytoreductive nephrectomy in the Era of TKI systemic therapy
Robert C. Flanigan

State-of-the-Art Lecture 7

The collaborative approach to complex pediatric urological conditions
Rama Jayanthi

Educational Forum 3: Pediatric UPJO- Can Canada agree?

Luis H. Braga, Rama Jayanthi VIEW

June 25


State-of-the-Art Lecture 8

The opioid epidemic and sexual dysfunction: Current challenges and a future roadmap for the practicing clinician
Hossein Sadeghi-Nejad

State-of-the-Art Lecture 9

What every urologist should know about neurogenic bladder
Anne Pelletier Cameron

Educational Forum 4: Challenges in incontinence

Sender Herschorn, Blayne K. Welk, Anne Pelletier Cameron VIEW

Podium Session 2: Pediatrics / Endourology

The FOXY study:  A randomized trial comparing the efficacy and safety of fesoterodine and oxybutynin XL in children with overactive bladder
Elizabeth Naud
Parental perceptions and attitudes towards disclosure of hypospadias repair
Udi Blankstein
Does breastfeeding reduce the risk of urinary tract infection in infants with prenatal hydronephrosis?
Melissa  McGrath
Effect of a bacterial urinary infection isolate on a calcium urolithiasis model
Jennifer Bjazevic
Double-blind, prospective, randomized clinical trial comparing regular and Moses modes of holmium laser lithotripsy: Preliminary results 
Ahmed Ibrahim

Educational Forum 5: Urethral stricture disease: Should I really be doing this? 

Gregory Bailly, Keith F. Rourke, Ronald T. Kodama VIEW

State-of-the-Art Lecture 10

Impact of treatment related to sexual dysfunction in urethral stricture disease
Run Wang

Educational Forum - Integrating immune-oncology within the current treatment of advanced urothelial carcinoma

Integrating immune-oncology within the current treatment of advanced urothelial carcinoma
Lori A. Wood, Peter C. Black

June 26


State-of-the-Art Lecture 11

The future of medical management for stone disease
Benjamin Canales

Educational Forum 6: Maximizing outcomes in your kidney stone patient in 2018

John D. Denstedt, Andrea Lantz, Benjamin Canales VIEW

Podium Session 4: Other Oncology

Predictors of a positive genetic test result in patients with a suspected hereditary kidney cancer syndrome: Results from a provincial medical genetics unit
Andrea Kokorovic
Patterns of bladder cancer recurrence after open and robotic radical cystectomy
Pierre-Alain Hueber
Optimizing the use of neoadjuvant chemotherapy in micropapillary bladder cancer: Validation of proposed risk classifiers
Jonathan Duplisea
Determinants of postoperative hospital stays in a cohort of bladder cancer patients undergoing radical cystectomy in Quebec, 2000-2013
Ahmed Zakaria
Validation of Real-time, Intraoperative, Surgical Competence (RISC) assessments linked to clinically relevant patient outcomes: A model of competency assessment in urology
Ethan D. Grober

CUA Guidelines Session

Introduction VIEW
VTE prophylaxis
Philippe Violette
RCC FU guidelines
Anil Kapoor
CUA Guidelines for Peyronie's Disease and Congenital Penile Curvature
Anthony Bella